IL7R gain-of-function mutations frequently co-occur with NOTCH1 mutations, and NOTCH1 mutations tend to be more common in IL7R mutant patients (75–90%) than in the general T-ALL population [23, 24, 58]. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.